COMMUNIQUÉS West-GlobeNewswire

Recommended Acquisition of Nightstar Therapeutics plc by Tungsten Bidco Limited, a Wholly-Owned Subsidiary of Biogen Switzerland Holdings GmbH; Posting of Scheme Document
09/04/2019
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY RESTRICTED JURISDICTION OR ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT [...]
Precision Therapeutics’ Subsidiary Helomics to Collaborate with Viome to Explore the Impact of the Gut Microbiome on Ovarian Cancer
09/04/2019
MINNEAPOLIS, April 09, 2019 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ: AIPT) (“Precision” or “the Company”) today announced a collaboration between its wholly owned subsidiary, Helomics, and Viome, a new [...]
Daré Bioscience, Inc. Prices Underwritten Public Offering of Common Stock
09/04/2019
SAN DIEGO, April 09, 2019 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ:DARE), today announced the pricing of an underwritten public offering of 4,575,000 shares of its common stock at a price of $1.10 per share. [...]
Driven Deliveries Inc. Announces Key Additions to their Management Team
09/04/2019
SAN DIEGO, April 09, 2019 (GLOBE NEWSWIRE) -- Driven Deliveries, Inc., (DRVD), the world’s first and only publicly traded cannabis delivery company, announced today the addition of Mr. Brad Dalmann to serve as the [...]
Nova Leap Health Corp. Engages Torrey Hills Capital
09/04/2019
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN HALIFAX, Nova Scotia, April 09, 2019 (GLOBE NEWSWIRE) -- NOVA [...]
Hemostemix Announces Enrollment Milestone in the ACP-01 Phase II Critical Limb Ischemia Clinical Trial
09/04/2019
CALGARY, Alberta, April 09, 2019 (GLOBE NEWSWIRE) -- Hemostemix Inc. (“ Hemostemix ” or the “ Company ”) (TSX VENTURE: HEM; OTCQB: HMTXF) is pleased to announce that it has reached an enrollment milestone in its [...]
Vaccinex, Inc. Summary of Key Data Presented at the 2019 Annual Meeting of the American Association for Cancer Research (AACR)
09/04/2019
First Interim Results of CLASSICAL-Lung Phase 1b/2 Study Demonstrate Up To 90 Percent Disease Control Rate and Increase in Immune Cells and Decrease in Immunosupressive Cells in Response to Combination Therapy with [...]
Mustang Bio to Present at the World Orphan Drug Congress USA 2019
09/04/2019
NEW YORK, April 09, 2019 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into [...]
Align Technology Completes Purchase of Raleigh Office Building
09/04/2019
Affirms commitment to continued innovation and regional growth with $58 million investment SAN JOSE, Calif., April 09, 2019 (GLOBE NEWSWIRE) -- Align Technology, Inc. (NASDAQ: ALGN), makers of the Invisalign® system, [...]
Harvest One Ensures Cannabis Supply with Greenbelt Acquisition-- CFN Media
09/04/2019
SEATTLE, April 09, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]
Innovation Pharmaceuticals Reports Enhancements in Manufacture of Brilacidin Phase 3 Drug Supply
09/04/2019
BEVERLY, Mass., April 09, 2019 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, is pleased to report that the Company has implemented yield and [...]
The Most Prevalent Cannabis E-commerce Platforms in Canada
09/04/2019
VANCOUVER, British Columbia, April 09, 2019 (GLOBE NEWSWIRE) -- Cannabis e-commerce platforms, both medical and recreational, are becoming increasingly important as Canada's legal marijuana market matures. However, [...]
TRHC Commends White House Report on Need for Innovative Technology Solutions to Improve Lives of Elderly and Disabled
09/04/2019
MOORESTOWN, N.J., April 09, 2019 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc . (TRHC) (NASDAQ: TRHC), a leading provider of technology-enabled solutions to mitigate medication risk, commends a recent report issued [...]
Allscripts to release first-quarter 2019 financial results May 2
09/04/2019
CHICAGO, April 09, 2019 (GLOBE NEWSWIRE) -- Allscripts Healthcare Solutions, Inc . (Nasdaq:MDRX) will report its financial results for the three months ended March 31, 2019, after the close of stock market hours on [...]
Inspire Medical Systems, Inc. to Report First Quarter 2019 Financial Results on May 7, 2019
09/04/2019
MINNEAPOLIS, April 09, 2019 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative and minimally invasive [...]
Cyclerion Announces the Appointment of Andreas Busch, Ph.D., as Chief Innovation Officer
09/04/2019
– Dr. Busch will lead Cyclerion’s Innovation Center and provide strategic oversight of the company’s soluble guanylate cyclase (sGC) portfolio – CAMBRIDGE, Mass., April 09, 2019 (GLOBE NEWSWIRE) -- Cyclerion [...]
Intra-Cellular Therapies Announces Presentation of Lumateperone Long-term Open Label Safety Study at the 2019 Congress of the Schizophrenia International Research Society
09/04/2019
NEW YORK, April 09, 2019 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, today [...]
T2 Biosystems and Clinicians to Share Clinical Data in Integrated Symposium and Poster Presentations at the European Congress of Clinical Microbiology & Infectious Diseases (ECCMID)
09/04/2019
Data will highlight how direct-from-whole blood innovations—the T2Bacteria, T2Candida and T2Resistance panels—positively impact patients with bloodstream infections LEXINGTON, Mass., April 09, 2019 (GLOBE NEWSWIRE) -- [...]
Inhibikase Therapeutics Announces Appointment of Elizabeth O’Farrell to its Board of Directors
09/04/2019
ATLANTA and BOSTON, April 09, 2019 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc., a pharmaceutical company developing protein kinase inhibitors for the treatment of neurological infections and neurodegenerative [...]

Pages